George Elston - Chief Financial Officer, Eyepoint Pharmaceuticals, Inc

As of June 23, 2021


George Elston Net Worth

  • Net worth is estimated to be at least $1.41B
  • Owns at least 40,000 units of Eyepoint Pharmaceuticals, Inc stock

George Elston Compensation at Eyepoint Pharmaceuticals, Inc in 2020

  • Earned a $440,000 salary
  • Received a total compensation of $775,704

George Elston Trading

  • Largest purchase of shares was 10,000 units , worth over $14.29K on November 18, 2019
  • In total has made about 6 transactions over 2 years
  • Usually trades in March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

George Elston Mailing Address

  • Mailing address is 124 Chatham Street Chatham NJ 07928 NJ

Eyepoint Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Nancy Lurker 2020 $581,957 - $482,460 $563,216 $454,508 $15,660 $2,097,801
Nancy Lurker 2019 $577,037 - $650,207 $693,165 $144,034 $15,340 $2,079,783
George Elston 2020 $440,000 - - $83,104 $236,940 $15,660 $775,704
George Elston 2019 $58,385 $20,000 - $635,555 - $2,068 $716,008
Dario Paggiarino 2020 $436,156 - $158,864 $185,417 $242,371 $15,660 $1,038,468
Dario Paggiarino 2019 $420,862 - - $275,775 $105,188 $15,340 $817,165
Scott Jones 2020 $376,250 - $158,864 $185,417 $212,135 $15,660 $948,326
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1314102/000156459021022639/eypt-def14a_20210622.htm

Eyepoint Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on November 17, 2021 by Nancy Lurker worth over $201.48K
  • In the last 3 years, insiders at Eyepoint Pharmaceuticals, Inc sold an estimated value of $374.99K and bought an estimated value of $22.02M
  • The most active traders are Nancy Lurker, President & CEO,  Dario Paggiarino, Chief Medical Officer,  and David Mazzo
  • Insider trading is most common in June, with the busiest year in 2019

EyePoint Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1